Best Alcohol and Drug Rehab NJ in Atco, NJ

Jeffrey A. Berman, MD, FASAM is a Diplomate and Fellow of the American Society of Addiction Medicine. He is the Executive Medical Director of Discovery Institute for Addictive Disorders in Marlboro, NJ and Clinical Assistant Professor of Psychiatry at the Robert Wood Johnson Medical School. He was recruited from Bergen Regional Medical Center, NJ’s largest acute psychiatric hospital, where he served as Director of Chemical Dependency Services to join Discovery Institute in Marlboro. Dr. Berman is a diplomate of the American Board of Psychiatry and Neurology (ABPN) in Adult and Addiction Psychiatry as well as Psychosomatic Medicine. He has been certified by the American Society of Addiction Medicine since 1988 and is Board Certified in Addiction Medicine (ABAM). Dr. Berman’s area of special interest in research and teaching is Pain Management and Co-occurring Opioid Dependence. He is also a strong advocate for Medication Assisted Treatment (MAT) for the chronic persistent mentally ill. Dr. Berman participated in NIDA’s clinical trials of Buprenorphine/Naloxone for treatment of heroin addiction in 2001. Since then he has developed innovative treatment programs for individuals with Co-occurring disorders as well as Substance Use Disorders. Dr. Berman served as Chief of Psychiatry at Fort Leavenworth, KS including the Department of Defense’s US Disciplinary Barracks located at Fort Leavenworth. He recently retired from the US Army Reserve after 22 years of service which included service in Operations Desert Storm and Iraqi Freedom. He is currently the Psychiatric Consultant to the Department of Immigration Health (DIHS), a division of Homeland security. Prior to coming to New Jersey, he served as Medical Director of Gieisinger Health Care’s Marworth chemical dependency center and consultant to pain management centers in New Jersey and Pennsylvania for issues of addiction, pain and co-occurring mood disorders. He has taken an active role in the medical treatment of HIV patients in all of these clinical settings.

Dr. Christodoulou has provided psychiatric emergency services and evaluations for over 20 years. He has taken a special interest in treating children and juveniles, as well as those who suffer from substance use disorders. Dr. Christodoulou is board certified by the American Board of Addiction Medicine and has certifications in both psychiatry and neurology.

David Dorschu, MS, has over eighteen years of experience in the substance abuse field, serving in various leadership positions which incorporate the entire continuum of care, including Clinical Director, Risk Management Director, QA Director, Outpatient Program Director, and currently as Chief Executive Officer of the RCA at Raritan Bay facility. David began his tenure at RCA in 2016 as CEO of the Lighthouse, a 133-bed facility located in Mays Landing, NJ. David has utilized these various leadership roles to form a treatment philosophy based on the latest, empirically supported research. “The patients we are so fortunate to serve have provided to us a tremendous gift: the willingness to share their pain and offer us a glimpse into their brokenness. They are under no obligation to do so, therefore we must treat this gift as a sacred trust and privileged responsibility.“ David earned his Master’s Degree in Counseling Psychology from Villanova University.